Resmed Inc. Stock
Resmed Inc. Stock
Resmed Inc. gained 0.300% compared to yesterday.
Resmed Inc. is currently one of the favorites of our community with 17 Buy predictions and no Sell predictions.
As a result the target price of 258 € shows a positive potential of 40.98% compared to the current price of 183.0 € for Resmed Inc..
Pros and Cons of Resmed Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
S********** s********
Cons
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Resmed Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Resmed Inc. | 0.300% | 6.519% | 7.331% | -23.206% | -12.230% | -9.540% | -20.157% |
| Agilent Technologies Inc. | -1.700% | -1.559% | 3.226% | 19.284% | 2.372% | 8.352% | -6.578% |
| Veeva Systems A | 1.200% | 7.840% | 13.812% | -29.073% | -7.702% | -4.820% | -36.988% |
| Boston Scientific | 1.250% | 4.084% | 8.487% | -55.957% | -50.221% | -14.080% | 5.384% |
Comments
ResMed (RMD) had its "buy" rating reaffirmed by UBS Group AG.
Show more
Ratings data for RMD provided by MarketBeat
ResMed (RMD) was given a new $276.00 price target by Royal Bank Of Canada. They now have an "outperform" rating on the stock.
Show more
Ratings data for RMD provided by MarketBeat
ResMed (RMD) was given a new $266.00 price target by KeyCorp. They now have an "overweight" rating on the stock.
Show more
Ratings data for RMD provided by MarketBeat